10.1042/BST20200270 Summary Keywords GLP-1, immunemetabolic signaling, metabolic disease, neuroendocrine peptides, orphan receptors, peptide therapeutics, polypharmacology Citation Niazi SK (2026) Beyond GLP-1: underexplored peptidereceptor systems as the next frontier in drug discovery
First, let's talk about the blood sugar control elements of GLP-1s
Proteinases and Their Receptors in Inflammatory Arthritis: An Overview
Redoviti pregled Redoviti pregled ovog praha moe omoguiti pravodobno razumijevanje njegove stabilnosti i promjena kvalitete
Therefore, a full medical review is essential before starting treatment, which is why we conduct one during your initial consultation
While Eli Lilly has traditionally invested more in R&D, its recent surge in buybacks and dividends signals a growing focus on investor returns